Your browser doesn't support javascript.
loading
Impact of Persistent Versus Paroxysmal Preoperative Atrial Fibrillation on In-Hospital, One-Year, and Late Clinical Outcomes Following Transcatheter Aortic Valve Implantation.
Kompella, Ritika; Amin, Hina; Mather, Jeff F; Hashim, Sabet W; McKay, Raymond G; McMahon, Sean R.
Afiliação
  • Kompella R; Department of Internal Medicine, University of Connecticut Health, Farmington, Connecticut.
  • Amin H; Department of Cardiology, Hartford Healthcare and Vascular Institute.
  • Mather JF; Department of Research Administration, Hartford Hospital, Hartford, Connecticut.
  • Hashim SW; Department of Cardiac Surgery, Hartford HealthCare Heart and Vascular Institute, Hartford, Connecticut.
  • McKay RG; Department of Cardiology, Hartford Healthcare and Vascular Institute. Electronic address: aymond.mckay@hhchealth.org.
  • McMahon SR; Department of Cardiology, Hartford Healthcare and Vascular Institute.
Am J Cardiol ; 2024 Jun 24.
Article em En | MEDLINE | ID: mdl-38925260
ABSTRACT
Previous reports on the impact of preexisting atrial fibrillation (AF) on clinical outcomes after transcatheter aortic valve implantation (TAVI) have presented limited data on the relative impact of paroxysmal versus persistent AF subtypes. We compared in-hospital, 1-year, and late clinical outcomes in 1,098 patients who underwent TAVI with preoperative AF (556 paroxysmal, 542 persistent) versus 1,787 patients without AF. The propensity-matched cohorts with AF (n = 643) and without AF (n = 686) did not differ with respect to baseline clinical characteristics, operative technique, or in-hospital TAVI complications. At 1-year, patients with AF had higher all-cause mortality (9.0% vs 6.1%, p = 0.046) and readmission rates (13.1 vs 8.8%, p = 0.014), with lower Kansas City cardiomyopathy questionnaire scores (77.8 ± 21.8 vs 84.3 ± 17.1, p <0.001). Echocardiographic follow-up (mean time 455 ± 285 days) demonstrated no significant intergroup differences in hemodynamic findings other than a progressive increase in left atrial volume index in patient subgroups (without AF 37.4 ± 14.7 ml/m2 vs paroxysmal AF 46.4 ± 21.4 ml/m2 vs persistent AF 60.5 ± 26.3 ml/m2, p <0.001). On late follow-up (mean time 49.0 [45.1 to 52.9] months), patients with persistent AF had worse all-cause mortality than patients without AF (hazard ratio 1.55, 95% confidence interval 1.17 to 2.06, p = 0.003), with no significant survival differences between the paroxysmal AF and without AF subgroups. In conclusion, patients with preexisting AF and patients without AF who underwent TAVI had similar in-hospital outcomes but worse 1-year mortality, hospital readmission, and quality of life outcomes. Compared with patients without AF, patients with persistent but not paroxysmal preexisting AF have higher late all-cause mortality at a mean follow-up of 49 months. Patients with persistent AF have higher levels of left atrial volume index than patients with paroxysmal AF and patients without AF on intermediate echocardiographic follow-up.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article